-
1 week ago | 
source.washu.edu | Brittney Wheeler
The Women’s Society of Washington University presented the Harriet K. Switzer Leadership Award and the Elizabeth Gray Danforth Scholarship to four exceptional students during its annual membership meeting this spring.
-
1 month ago | 
medicine.washu.edu | Mark Reynolds |Brittney Wheeler
Love for sports can take a toll on aging bodies, with deteriorating joints leading to painful osteoarthritis, especially in the hip. For hardcore athletes and weekend warriors, a total hip replacement often limits participation in high impact or intense physical activities.
-
1 month ago | 
medicine.washu.edu | Mark Reynolds |Brittney Wheeler
The fatigue and lack of motivation that many cancer patients experience near the end of life have been seen as the unavoidable consequences of their declining physical health and extreme weight loss. But new research from Washington University School of Medicine in St. Louis challenges that long-held assumption, showing instead that these behavioral changes stem from specific inflammation-sensing neurons in the brain.
-
1 month ago | 
medicine.washu.edu | Mark Reynolds |Brittney Wheeler
Autoimmune diseases, which are estimated to affect more than 15 million people in the U.S., occur when the body responds to immune-system false alarms, and infection-fighting first responders are sent out to attack threats that aren’t there. Scientists have long understood how the false alarms get triggered, but the second step of dispatching the immune response has been a mystery.
-
Jan 22, 2025 | 
source.washu.edu | Kristina Sauerwein |Brittney Wheeler
Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study reporting one in eight Americans has taken or is currently using the drugs to treat diabetes, heart disease or obesity. Formally, these drugs are known as glucagon-like peptide-1 receptor agonists (GLP-1RA) and include Mounjaro and Zepbound.
-
Jan 17, 2025 | 
medicine.washu.edu | Marta Wegorzewska |Brittney Wheeler
Individuals with sickle cell disease — a chronic illness where misshapen, sticky blood cells clump together, reducing oxygen delivery to organs — are at a higher risk for stroke and resulting cognitive disability. But even in the absence of stroke, many such patients struggle with remembering, focusing, learning and problem solving, among other cognitive problems, with many facing challenges in school and in the workplace.
-
Jan 17, 2025 | 
medicine.washu.edu | Julia Strait |Brittney Wheeler
Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.
-
Jan 16, 2025 | 
medicine.washu.edu | Julia Strait |Brittney Wheeler
A new type of cell-based immunotherapy shows promise for B-cell lymphomas and — due to innovations in manufacturing — could make future cellular immunotherapies less expensive and more accessible to patients. A phase 1 clinical trial found one such immunotherapy to be safe for patients with several types of B-cell lymphoma, a type of blood cancer.
-
Jan 10, 2025 | 
source.washu.edu | Brittney Wheeler
The Internal Medicine Residency Program at WashU Medicine has received the Accreditation Council for Graduate Medical Education 2025 Barbara Ross-Lee, DO Diversity, Equity, and Inclusion Award.
-
Jan 7, 2025 | 
source.washu.edu | Brittney Wheeler
Mice infected with the bacteria that cause tuberculosis (TB) fared better when treated with an experimental compound that modulates immune responses than untreated mice did, according to a study led by Christina Stallings, a professor of molecular microbiology at WashU Medicine. The findings, published Dec. 4 in Cell Host & Microbe, could pave the way toward new and more-effective therapies for TB that combine traditional antibiotics with drugs that optimize the immune response to infection.
